Terumo Interventional Systems launches dual-layer micromesh carotid stent after FDA approval

Michael Walter | May 29, 2025 | Cardiovascular Business | Interventional Cardiology

Roadsaver Carotid Stent System image courtesy of Terumo Interventional Systems.

Terumo Interventional Systems, a division of Terumo Corporation, has announced that its Roadsaver Carotid Stent System is now commercially available for the first time. The device just gained U.S. Food and Drug Administration (FDA) approval for the treatment of carotid artery stenosis in patients who face a high risk of complications following carotid endarterectomy.

The Roadsaver device works with the company’s Nanoparasol Embolic Protection System. It is a closed-cell stent, but still flexible like an open-cell stent, and available in multiple sizes. It was built to target de novo atherosclerotic or post-endarterectomy restenotic lesions in the internal carotid arteries or at the carotid bifurcation

According to Terumo, Roadsaver is the first dual-layer micromesh carotid stent on the U.S. market. In addition, the company said it is the only device of its kind that prevents plaque protrusion by keeping plaque to the vessel wall.

Chris Pearson, executive vice president of U.S. commercial operations for Terumo Interventional Systems, described the newly available device as “yet another example of our unrelenting pursuit of achieving better outcomes for patients. Its rapid delivery and accurate placement drive procedure predictability and efficiency, differentiating it from other carotid artery stents on the market and providing a level of confidence unmatched in the industry,” he added in a prepared statement.

This is a limited market release of the Roadsaver technology; a full release is expected to occur in the second half of 2025.

Medtronic expands carotid portfolio with Contego Medical deal

FDA gives green light to 3-in-1 carotid stent system designed to limit strokes

How a big CMS update on carotid stenting could impact interventional cardiology

CMS changes coverage policy for carotid stenting to make it more widely available

Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Exec

Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.